Revenue and Profit Performance - Revenue from maternity service business decreased by 10.6% to HKD 274.7 million due to RMB depreciation, cautious consumer spending, and losses from newly opened maternity centers[6] - Revenue for the period was approximately HKD 274.7 million, a decrease of 10.6% compared to HKD 307.2 million in the same period last year, primarily due to RMB depreciation and cautious consumer spending[9] - Gross profit for the period was HKD 70.2 million, a decrease of 24.7% compared to HKD 93.2 million in the same period last year, with a gross margin of 25.5% compared to 30.3% last year[9] - Net loss for the period was HKD 39.4 million, an increase of HKD 16.4 million compared to a net loss of HKD 22.9 million in the same period last year, driven by RMB depreciation, cautious consumer spending, and losses from newly opened centers[13] - Adjusted loss for the period was HKD 6.2 million, compared to an adjusted profit of HKD 18.0 million in the same period last year, after adjusting for non-cash and one-time items[16] - Revenue for the six months ended June 30, 2024, decreased to HKD 274.735 million from HKD 307.229 million in the same period in 2023, representing a decline of approximately 10.6%[46] - Gross profit for the period dropped to HKD 70.173 million from HKD 93.178 million year-over-year, reflecting a decrease of about 24.7%[46] - Operating loss for the six months ended June 30, 2024, was HKD 15.633 million, compared to an operating profit of HKD 13.535 million in the same period in 2023[46] - Net loss attributable to the company's owners increased to HKD 39.194 million from HKD 23.656 million year-over-year[47] - Total comprehensive loss for the period was HKD 54.342 million, slightly lower than the HKD 63.366 million loss in the same period in 2023[47] - Revenue from external customers for the six months ended June 30, 2024, was 274,735 thousand HKD, a decrease from 307,229 thousand HKD in the same period in 2023[64] - Revenue from maternity services decreased to HK$274.735 million from HK$307.229 million in the previous year[56] - The company reported a period loss of 22,925 thousand HKD for the six months ended June 30, 2024, after deducting unallocated expenses of 38,900 thousand HKD[59] - The company's attributable basic and diluted loss for the period was HK$39,194,000, compared to HK$23,656,000 in the same period last year[70] Business Expansion and Operations - The company expanded its core maternity business to 12 cities with 21 stores, including new entries in Foshan and Chongqing[5] - The company opened 21月子中心门店 across 12 cities, including new locations in Foshan and Chongqing, as part of its expansion strategy[8] - Administrative expenses increased by 16.2% to HKD 35.6 million, mainly due to the accelerated expansion under the "Five-Year Fifty-City Plan"[10] - The company reported a segment performance of 15,975 thousand HKD for the six months ended June 30, 2024, with the maternity services segment contributing 16,775 thousand HKD[59] - Total assets as of June 30, 2024, were 1,893,487 thousand HKD, with the maternity services segment accounting for 1,419,046 thousand HKD[60] - Total liabilities as of June 30, 2024, were 1,135,580 thousand HKD, with the maternity services segment contributing 685,954 thousand HKD[60] - The maternity services segment reported a segment loss of HK$3.184 million, contributing to a total segment loss of HK$3.881 million[57] - Unallocated expenses, including depreciation and general office expenses, amounted to HK$35.474 million[57] Financial Management and Debt - The company implemented a "three-for-one" rights issue to alleviate debt issues caused by the pandemic, with active participation from shareholders[4] - Financial costs decreased by 24.7% to HKD 24.1 million, primarily due to reduced interest expenses on borrowings and lease liabilities[12] - The company completed a rights issue on May 14, 2024, issuing 1,478,338,324 rights shares at HK$0.042 per share, raising approximately HK$56.30 million net of expenses[30] - Of the net proceeds from the rights issue, HK$39.7 million was used to repay outstanding debts, HK$5.0 million for expanding the maternity service business, and HK$4.5 million for general working capital[31] - The remaining unused net proceeds from the rights issue are expected to be utilized by the first quarter of 2025, subject to market conditions[32] - The outstanding balance of the loan related to the acquisition of Shenzhen Aidikang Maternal and Child Health Management Co., Ltd. was approximately RMB 291.5 million as of June 30, 2024, with 94.95% equity in Shenzhen Aidikang pledged as collateral[27] - The company's subsidiary, Guangdong Wanjia Health Industry Group, has a loan facility of RMB 340,000,000 from Dongguan Rural Commercial Bank, with an interest rate ranging from 5.40% to 6.75%, and RMB 313,303,000 was utilized as of June 30, 2024[78] - Shenzhen Aidigong secured a RMB 3,000,000 working capital loan from China CITIC Bank with an interest rate of the bank's base rate plus 0.85%, due for repayment on November 26, 2024[78] - As of June 30, 2024, the company's total borrowings were HKD 316,527,000, with RMB-denominated borrowings accounting for the majority[78] - The company has bonds payable of HKD 45,000,000 due between October 2024 and March 2025, with interest rates ranging from 13.02% to 14.43%[79] Corporate Governance and Shareholder Structure - The company's board underwent significant changes to improve governance and decision-making capabilities, reducing the number of directors and introducing experienced industry professionals[4] - The company has adopted the Corporate Governance Code and complies with its provisions, with Ms. Wang Aier appointed as Executive Director, Chairman, and CEO on April 7, 2024[41] - As of June 30, 2024, the company's directors and top executives held significant equity stakes, with Ms. Wang Aier holding 9.05% and Mr. Li Jialong holding 6.31% and 3.38% of the issued share capital respectively[33] - Ms. Zhu Yufei holds a beneficial interest in 167,161,755 shares and is deemed to have interests in 466,666,666 shares through controlled entities, totaling 10.72% of the issued share capital[35] - Mr. Zhang Weiquan is deemed to have interests in 372,989,671 shares through Champion Dynasty Limited, representing 6.31% of the issued share capital[35] - Zhuhai Deyou Bohui Enterprise Management Consulting Center holds 374,531,836 shares, representing 6.33% of the issued share capital[35] - Zhuhai Gaoling Deyou Investment Management Co., Ltd. is deemed to have interests in 374,531,836 shares through Zhuhai Deyou Bohui, representing 6.33% of the issued share capital[35] Share Issuance and Capital Structure - Issued 1,478,338,324 new shares at HKD 0.042 per share on May 14, 2024, increasing share capital by HKD 56,300,000[18] - Total issued ordinary shares increased to 5,913,353,298 as of June 30, 2024, from 4,435,014,974 on December 31, 2023[19] - Share options plan allows for a maximum of 431,501,497 options, representing 10% of issued share capital as of June 28, 2022[23] - Share incentive plan allows for a maximum of 3% of issued share capital to be awarded as incentive shares[24] - The company granted 63,500,000 reward shares to 69 selected individuals under the Share Award Scheme on November 12, 2021, with specific vesting conditions. As of June 30, 2024, none of these reward shares have been exercised[26] - A share consolidation was approved and became effective on July 29, 2024, consolidating every 40 existing shares into 1 consolidated share[80] - The company proposed a share placement under a special mandate, aiming to issue up to 44,350,000 shares at HKD 1.68 per share, with the placement still ongoing as of the report date[81] Asset and Liability Management - Net asset value increased by HKD 1,958,000 to HKD 757,907,000 as of June 30, 2024, compared to HKD 755,949,000 on December 31, 2023[18] - Current ratio decreased to 1.07 as of June 30, 2024, from 1.16 on December 31, 2023[18] - Bank and cash balances decreased to HKD 70,897,000 as of June 30, 2024, from HKD 80,303,000 on December 31, 2023[20] - Asset-liability ratio improved to 0.78 as of June 30, 2024, from 0.83 on December 31, 2023[20] - Structured bank deposits increased to HKD 21,496,000 as of June 30, 2024, from HKD 20,009,000 on December 31, 2023[21] - Property, plant, and equipment decreased to HKD 88.355 million as of June 30, 2024, from HKD 101.500 million at the end of 2023[48] - Intangible assets declined to HKD 714.331 million as of June 30, 2024, from HKD 731.031 million at the end of 2023[48] - Total equity attributable to the company's owners increased slightly to HKD 740.534 million as of June 30, 2024, from HKD 737.702 million at the end of 2023[49] - Non-current liabilities decreased to HKD 713.999 million as of June 30, 2024, from HKD 819.790 million at the end of 2023[49] - Deposits increased to HK$53,725,000 as of June 30, 2024, from HK$43,234,000 at the end of 2023[72] - Other receivables totaled HK$389,442,000 as of June 30, 2024, compared to HK$385,963,000 at the end of 2023[72] - Trade payables decreased to HK$19,741,000 as of June 30, 2024, from HK$20,513,000 at the end of 2023[74] - Contract liabilities related to maternity services were HK$143,682,000 as of June 30, 2024, down from HK$149,925,000 at the end of 2023[76] - Total borrowings decreased to HK$316,527,000 as of June 30, 2024, from HK$330,809,000 at the end of 2023[77] Cash Flow and Financial Activities - Cash flow from operating activities was negative at HK$1.796 million, while cash used in investing activities was HK$27.740 million[51] - The company's cash flow from financing activities was negative at HK$5.790 million, primarily due to share issuance costs[50] - Cash and cash equivalents decreased by HK$8.873 million, ending at HK$70.897 million[51] - The company issued convertible preferred shares worth HK$71.015 million[50] - Exchange rate differences from overseas operations resulted in a loss of HK$31.011 million[50] - The fair value change of equity investments through other comprehensive income was a loss of HK$7.600 million[50] Employee and Administrative Costs - Total employee cost increased to HKD 118,485,000 in 2024 from HKD 112,396,000 in 2023[22] - Employee costs, including directors' remuneration, totaled 118,485 thousand HKD for the six months ended June 30, 2024, an increase from 112,396 thousand HKD in the same period in 2023[68] - Depreciation of property, plant, and equipment for the six months ended June 30, 2024, was 13,656 thousand HKD, a decrease from 15,997 thousand HKD in the same period in 2023[68] Other Financial and Operational Metrics - Sales and distribution expenses decreased by 2.6% to HKD 57.2 million, driven by improved marketing efficiency[11] - The company did not declare any interim dividend for the period, consistent with the previous year[17] - No interim dividend was recommended for the period ending June 30, 2024 (same as the previous year)[69] - The weighted average number of ordinary shares for calculating basic and diluted loss per share was 4,345,015[70] - Non-current assets in China as of June 30, 2024, were 1,355,440 thousand HKD, a decrease from 1,422,390 thousand HKD as of December 31, 2023[64] - Other income for the six months ended June 30, 2024, was 6,985 thousand HKD, a decrease from 9,747 thousand HKD in the same period in 2023[65] - The company reported a tax credit of 337 thousand HKD for the six months ended June 30, 2024, compared to a tax expense of 4,518 thousand HKD in the same period in 2023[66] - The company maintains a prudent treasury policy, with the majority of cash and cash equivalents held in major financial institutions in mainland China[40] - The company did not purchase, sell, or redeem any listed securities during the period[42] - The Audit Committee reviewed the unaudited interim financial statements and found them in compliance with relevant accounting standards and regulations[45]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容 而引致之任何損失承擔任何責任。 AIDIGONG MATERNAL & CHILD HEALTH LIMITED 愛帝宮母嬰健康股份有限公司 （股份代號 ： 286） （於百慕達註冊成立之有限公司） 截至二零二四年六月三十日止六個月之中期業績公告 愛帝宮母嬰健康股份有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此公佈本公 司及其附屬公司（統稱「本集團」）截至二零二四年六月三十日止六個月（「本期間」）之 未經審核綜合中期業績，連同二零二三年同期之比較數字如下： 財務概要及經營數據摘要 | --- | --- | --- | |-----------------------------|--------------|------------------------| | | | 截至六月三十日止六個月 | | | 二零二四年 | 二零二三年 | | | 千港元 | 千港元 | | | （未經審核） | （未經審核） | | | | ...

年報 2023 （於百慕達註冊成立之有限公司） ( : 286) 股份代號 ...

刊發二零二三年年報 本公司載有上市規則附錄D2所規定相關資料之本年度年報將適時刊登於聯交所及 本公司網站，並將寄發予本公司股東。 致謝 於截至二零二三年及二零二二年十二月三十一日止年度的每股攤薄虧損與每股基本虧損一 致。 28 11. 應收貿易款項 | --- | --- | --- | |-----------------------|------------|------------| | | | | | | 二零二三年 | 二零二二年 | | | 千港元 | 千港元 | | | | | | 應收貿易款項 | – | 4,798 | | 減： 預期信貸虧損撥備 | – | (635) | | | | | | | – | 4,163 | 於本年度，本集團並無向其客戶授出任何信貸期（二零二二年：30至90日）。應收貿易款項（扣 除預期信貸虧損撥備並根據發票日期列報）於報告期末之賬齡分析如下： | --- | --- | --- | |-------------|------------|------------| | | | | | | 二零二三年 | 二零二二年 | | | 千港元 | 千港元 | | 0 ...

爱帝宫 ( 愛 帝 宮 母 嬰 健 康 股 份 有 限 公 司 (於百慕建註冊成立之有限公司) (股份代號 : 286) 頁次 簡明綜合權益變動表 22 公司資料 2 1 東莞銀行股份有限公司 招商銀行股份有限公司 中國建設銀行股份有限公司 招商永隆銀行有限公司 東莞農村商業銀行股份有限公司 東亞銀行有限公司 中期報告 2023 目錄 目錄 簡明綜合財務狀況報表 20 簡明綜合財務報表附註 24 愛帝宮母嬰健康股份有限公司 • 中期報告二零二三年 | --- | --- | |--------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------| | | | | 董事 | 註冊成立地點 | | 執行董事 | 百慕達 | | 朱昱霏女士 （主席兼行政總裁） 張偉權先生 | 註冊辦事處 | | 林江先生 ...

上文呈報分部收入指來自外部客戶之收入。兩個年度同期均無內部分部銷售。 | --- | --- | --- | |----------------------------------------------|-------------------------------------|--------------| | | 截至六月三十日止六個月 \n二零二三年 | 二零二二年 | | | （未經審核） | （未經審核） | | | 千港元 | 千港元 | | | | | | 虧損 | | | | 用於計算每股基本及攤薄盈利之虧損 | | | | （本公司擁有人應佔期間虧損） | (23,656) | (61,505) | | 股份數目（千股） | | | | 用於計算每股基本及攤薄虧損之普通股加權平均數 | 4,345,015 | 4,289,480 | 於二零二一年十一月十二日，本公司根據股份獎勵計劃以根據一般授權發行 股份之形式向其項下之69名選定人士授予63,500,000股獎勵股份，並為承授人 設定數項行使條件，承授人僅可於達成條件後行使其獎勵股份（除非獲得本 公司之豁免）。於二零二二年年報日期，概無行 ...

愛 帝 宮 母 嬰 健 康 股 份 有 限 公 司 (於百慕連註冊成立之有限公司) (股份代號 : 286) 公司資料 2 管理層討論與分析 13 35 99 215 公司資料 尊敬的股東： 我用三個數字來總結。 第三個數字是「 132」。珠海實驗局二零二二年單月簽單量已經到了55張單。是珠海單月簽單量最大的月子中心。它用五個 月的時間就做到了珠海的第「一」名。目前珠海團隊已經準備在珠海簽下第「三」家店。所以我們要欣喜的告訴大家。現在我 們版圖上的以店數計的第「二」大城市已經是珠海了，做到這件事我們只用了很短的時間。同時，這件事也告訴市場，我們 是具有強大的系統化能力的，這種系統化的能力是時間和歷史積累出來的，絕不是短時間內燒點錢就能燒出來的，這種系 統化的能力可以讓我們隨時重塑團隊，重塑品牌，重塑市場。 第一個數字是「23」，「2」代表「兩」個品牌：一個品牌就是愛帝宮，還有一個新推出的品牌月格格。「3」代表「三」支團隊：三 支團隊分別是經典愛帝宮團隊，創新愛帝宮團隊以及月格格團隊。前兩支團隊將繼續使用愛帝宮這個品牌來開疆拓土，而 月格格團隊將完全使用獨立的新品牌進行擴張。 我們謹此對股東之鼎力支持，以及本公 ...

AIDIGONG MATERNAL & CHILD HEALTH LIMITED 愛帝宮母嬰健康股份有限公司 （股份代號 ： 286） （於百慕達註冊成立之有限公司） | --- | --- | --- | --- | |--------------------|-------|-----------------------|---------------------| | | 附註 | 二零二二年 \n千港元 | 二零二一年 \n千港元 | | 收入 銷售成本 | 3 | 679,946 (581,206) | 642,573 (437,161) | | | | | | | 毛利 | | 98,740 | 205,412 | | 其他收入 | 5 | 31,481 | 27,001 | | 行政費用 | | (121,023) | (63,421) | | 銷售及分銷費用 | | (148,453) | (107,479) | | 攤佔聯營公司之業績 | | (248) | (802) | | --- | --- | --- | --- | |-------------------------------- ...

爱帝宫 愛 帝 宮 母 嬰 健 康 股 份 有 限 公 司 (於百慕達註冊成立之有限公司) (股份代號: 286) the collection 目錄 目錄 公司資料 2 簡明綜合損益及其他全面收益報表 3 簡明綜合財務狀況報表 5 簡明綜合權益變動表 7 頁次 簡明綜合現金流量表 8 簡明綜合財務報表附註 9 主席報告 25 管理層討論與分析 29 愛帝宮母嬰健康股份有限公司 • 中期報告二零二二年 1 公司資料 | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------| | 董事 | 註冊成立地點 | | 執行董事 ...

蛋糕信息 2 0 2 1 年 報 愛 帝 宮 母 嬰 健 康 股 份 有 限 公 司 (股份代號: 286) 目錄 | --- | --- | |----------------------------|-------| | 目錄 | | | | | | 公司資料 | 2 | | 主席報告 | 3 | | 業務回顧 | 8 | | 本年業績 | 14 | | 管理層討論與分析 | 16 | | 董事會報告 | 23 | | 董事及高級管理層簡介 | 35 | | 企業管治報告 | 39 | | 環境、社會及管治報告 | 61 | | 獨立核數師報告 | 96 | | 綜合損益及其他全面收益報表 | 101 | | 綜合財務狀況報表 | 103 | | 綜合權益變動表 | 105 | | 綜合現金流量表 | 107 | | 綜合財務報表附註 | 109 | | 五年財務概要 | 223 | * 中英文版本如有任何歧義，概以英文版本為準 1 公司資料 | --- | --- | |------------------------------------------------------------------- ...